Novo CEO pressed by Senate to cut charges of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen told lawmakers the corporate would consider new talks with insurers about the record prices of Wegovy and copyright when they pledge to help keep the medicines on their formularies. The deal needs to https://kethek.com/